MedPage Today on MSN9 小时
Varipulse Returns; HCM Genes Reconsidered; Early Blood Test for Preeclampsia?
To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...
TCTMD7 小时
HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt
The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.
Solid Biosciences reports initial clinical data from INSPIRE DUCHENNE trial
Solid Biosciences (SLDB) announced initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy ...
Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene ...
Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...